MEMORY PHARMACEUTICALS CORP 4

4 · MEMORY PHARMACEUTICALS CORP · Filed Dec 20, 2004

Form 4

Period: 2004-12-16

DirectorPresident & Co-Founder

Transactions

Sale
Common Stock
2004-12-20$5.75/sh−27$155→ 182,432 total
Exercise/Conversion
Common Stock
2004-12-17$0.75/sh+19,517$14,638→ 182,432 total
Exercise/Conversion
Employee Stock Option (Right to Buy)
2004-12-16−187→ 0 total
Exercise: $0.54Exp: 2010-01-26→ Common Stock (187 underlying)
Exercise/Conversion
Common Stock
2004-12-20$0.75/sh+27$20→ 182,459 total
Exercise/Conversion
Common Stock
2004-12-16$0.75/sh+513$385→ 163,615 total
Exercise/Conversion
Common Stock
2004-12-16$0.54/sh+187$101→ 163,102 total
Exercise/Conversion
Employee Stock Option (Right to Buy)
2004-12-16−513→ 73,821 total
Exercise: $0.75Exp: 2010-08-01→ Common Stock (513 underlying)
Exercise/Conversion
Employee Stock Option (Right to Buy)
2004-12-20−27→ 54,277 total
Exercise: $0.75Exp: 2010-08-01→ Common Stock (27 underlying)
Exercise/Conversion
Employee Stock Option (Right to Buy)
2004-12-17−19,517→ 54,304 total
Exercise: $0.75Exp: 2010-08-01→ Common Stock (19,517 underlying)
Sale
Common Stock
2004-12-16$5.75/sh−700$4,025→ 162,915 total

Footnotes (3)

[F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2004, as amended on November 22, 2004.
[F2]Fully vested.
[F3]Only represents the derivative securities of this class.

Documents

2 files